title: Can optimal drug dosing during ECMO improve outcomes?
authors.affiliation: Critical Care Research Group, Adult Intensive Care Services, The Prince Charles Hospital and The University of Queensland, Rode Road, Chermside, Brisbane, QLD, 4032, Australia, kiran_shekar@health.qld.gov.au.
authors.forename: Kiran
authors.initials: K
authors.lastname: Shekar
authors.forename: John F
authors.initials: JF
authors.lastname: Fraser
authors.forename: Jason A
authors.initials: JA
authors.lastname: Roberts
mesh_terms: D003422:Critical Care / Q000639:trends*; D015199:Extracorporeal Membrane Oxygenation / Q000639:trends*; D006801:Humans; D012128:Respiratory Distress Syndrome / Q000628:therapy*
references.citation: BMC Anesthesiol. 2012 Nov 28;12:29
references.pmid: 23190792
references.citation: Intensive Care Med. 2013 Nov;39(11):2028-30
references.pmid: 23903779
references.citation: BMC Anesthesiol. 2013 Mar 21;13:7
references.pmid: 23517311
references.citation: Crit Care. 2012 Oct 15;16(5):R194
references.pmid: 23068416
references.citation: J Crit Care. 2012 Dec;27(6):741.e9-18
references.pmid: 22520488